Contributions of IRF5 to Chikungunya Viral Arthritis
IRF5 对基孔肯雅病毒性关节炎的贡献
基本信息
- 批准号:9224103
- 负责人:
- 金额:$ 13.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-03-01 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute DiseaseAedesAffectAldehyde-LyasesAlphavirusAnkleAntinuclear AntibodiesAntiviral AgentsApoptosisArthralgiaArthritisAutoimmune DiseasesAutoimmunityB-LymphocytesBinding SitesBiochemistryC57BL/6 MouseCD19 geneCRISPR/Cas technologyCartilageCell LineCellsChikungunya virusChronicChronic DiseaseClinicalCommunicable DiseasesCreatinineCulicidaeCytometryDataDendritic CellsDengue VirusDiamondDiseaseDisease OutbreaksDoctor of PhilosophyEpidemicEtiologyFlavivirusFoundationsGene DosageGenesGeneticGenetic PolymorphismGenetic TranscriptionGoalsHaitiHandHaplotypesHematopoieticHistologyHumanITGAX geneImmuneImmune Cell ActivationImmune responseImmunologicsImmunologyImmunotherapyIn VitroIndividualInfectionInfiltrationInflammatoryInflammatory ArthritisInstitutionInterferonsInternal MedicineInternationalJointsKnock-in MouseKnock-outKnockout MiceKnowledgeLaboratoriesLaboratory ResearchLeukocyte TraffickingLeukocytesLinkMeasuresMediatingMedical ResearchMedicineMentorsMetabolicModelingMolecular BiologyMusMuscleMyeloid CellsMyositisNatural ImmunityOklahomaPathogenesisPathologyPatientsPeripheralPhenotypePhosphotransferasesPhysiciansPolyarthritidesPopulationPostdoctoral FellowPrimary InfectionPrincipal InvestigatorProductionPublic HealthPublicationsReportingResearchResearch PersonnelReunion IslandRheumatoid ArthritisRheumatologyRiskRoleSaintsScientistSclerodermaSerumSeveritiesSeverity of illnessSpecialistSwellingSymptomsSynovitisSystemic Lupus ErythematosusT-LymphocyteTechnologyTestingTrainingTransaminasesTransgenic OrganismsUnited StatesUniversitiesViral ArthritisViral PathogenesisVirusVirus DiseasesVirus ReplicationWashingtonWest Nile virusWristZika Virusantiviral immunitybasebonebone erosioncareer developmentcell typechikungunyacohortcytokinedefined contributiondesigndisease phenotypeepidemiology studyfootgenetic risk factorgenome editinghuman diseaseinsertion/deletion mutationlymph nodesmacrophagemicroCTmonocytemouse Cre recombinasemouse modeloverexpressionpathogenpersistent symptomprofessorprogramspromoterprotein expressiontranscription factorvector mosquitoviral RNAvirology
项目摘要
Project Summary/Abstract
The goal of this proposal is to develop the applicant into an independent investigator with a research
program that examines the intersection of autoimmunity and antiviral immunity. The principal investigator (PI)
previously received his PhD training in biochemistry and molecular biology while studying immune
mechanisms of leukocyte trafficking at the Oklahoma Medical Research Foundation. As of 2015, the PI has
completed his clinical training in internal medicine and rheumatology and is currently a post-doctoral fellow
receiving formal training in immunology and virology at Washington University in Saint Louis.
The mentor is Dr. Michael Diamond, Professor of Medicine at Washington University, Associate
Director of the Center for Human Immunology and Immunotherapy Programs, and an established leader in the
fields of innate immunity and viral pathogenesis. Dr. Diamond has over 270 publications with special expertise
in studies of flaviviruses (e.g., West Nile, Dengue, and Zika viruses) and alphaviruses (e.g., Chikungunya
virus). Dr. Diamond is an infectious disease specialist who provides a model of a successful physician-scientist
to the applicant at Washington University, an internationally recognized premier academic institution.
Chikungunya virus (CHIKV) is an arthritogenic alphavirus that causes acute and chronic synovitis in a
distribution that mimics seronegative rheumatoid arthritis. Epidemiological studies conducted after the Reunion
Island CHIKV outbreak in 2006 suggest that a majority of patients infected with CHIKV progress to chronic
arthralgias and arthritis. At present, the role of specific interferon (IFN) stimulated genes and transcription
factors during CHIKV infection is still being defined. IFN regulatory factor (IRF)5 is a transcription factor that is
activated during viral infection and is known to upregulate expression of IFN stimulated genes, promote
production of proinflammatory cytokines, and enhance apoptosis under certain conditions.
Polymorphisms resulting in overexpression of human IRF5 are associated with the risk of developing
systemic lupus erythematosus and rheumatoid arthritis. We hypothesize that the severity and duration of
CHIKV arthritis also may be related to IRF5 polymorphisms that modulate the antiviral immune response
during acute infection. Here, we propose to test the contribution of IRF5 expression globally and in specific cell
types using an established mouse model of CHIKV arthritis. We also propose to generate knock-in mice that
ectopically express IRF5 to test the effect of IRF5 gene dosage on the pathogenesis of CHIKV arthritis. Using
these approaches, the applicant will gain expertise in immunology, virology, autoimmunity, and viral arthritis.
This will establish a foundation for an independent research program that will study interactions between host
genetic risk factors and pathogens that may act to trigger chronic rheumatologic diseases.
项目总结/摘要
该提案的目标是将申请人发展成为一名独立的调查员,
一个研究自身免疫和抗病毒免疫交叉的项目。主要研究者(PI)
此前,他曾在生物化学和分子生物学博士培训,同时研究免疫
俄克拉荷马州医学研究基金会的白细胞运输机制。截至2015年,PI
完成了内科和风湿病学的临床培训,目前是博士后研究员
在圣刘易斯的华盛顿大学接受免疫学和病毒学的正式培训。
导师是华盛顿大学医学教授迈克尔·戴蒙德博士,
人类免疫学和免疫治疗项目中心主任,
先天免疫和病毒发病机制领域。戴蒙德博士有超过270篇具有特殊专长的出版物
在黄病毒的研究中(例如,西尼罗河病毒、登革热病毒和寨卡病毒)和甲病毒(例如,屈曲
病毒)。戴蒙德博士是一位传染病专家,他提供了一个成功的医生-科学家的典范。
申请人在华盛顿大学,一个国际公认的首要学术机构。
基孔肯雅病毒(CHIKV)是一种致关节炎的甲病毒,可引起急性和慢性滑膜炎,
类似血清阴性类风湿性关节炎的分布。团聚后进行的流行病学研究
2006年的岛屿CHIKV爆发表明,大多数感染CHIKV的患者进展为慢性CHIKV。
关节痛和关节炎。目前,特异性干扰素(IFN)刺激基因和转录的作用
CHIKV感染期间的因素仍在定义中。IFN调节因子(IRF)5是一种转录因子,
在病毒感染期间被激活,并且已知上调IFN刺激基因的表达,促进
促炎细胞因子的产生,并在某些条件下增强细胞凋亡。
导致人IRF 5过表达的多态性与发生以下疾病的风险相关:
系统性红斑狼疮和类风湿性关节炎。我们假设,
CHIKV关节炎也可能与调节抗病毒免疫应答的IRF 5多态性有关
在急性感染期间。在这里,我们建议测试IRF 5表达的贡献,在全球和特定的细胞
使用已建立的CHIKV关节炎小鼠模型进行分型。我们还建议产生敲入小鼠,
异位表达IRF 5以测试IRF 5基因剂量对CHIKV关节炎发病机制的影响。使用
通过这些方法,申请人将获得免疫学、病毒学、自身免疫和病毒性关节炎方面的专业知识。
这将为一个独立的研究项目奠定基础,该项目将研究宿主之间的相互作用。
遗传危险因素和病原体可能会引发慢性风湿病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan J Miner其他文献
MDA5 and autoimmune disease
MDA5 与自身免疫性疾病
- DOI:
10.1038/ng.2959 - 发表时间:
2014-04-28 - 期刊:
- 影响因子:29.000
- 作者:
Jonathan J Miner;Michael S Diamond - 通讯作者:
Michael S Diamond
Jonathan J Miner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan J Miner', 18)}}的其他基金
Role of TREX1 in age-related hereditary leukoencephalopathy
TREX1 在年龄相关遗传性白质脑病中的作用
- 批准号:
10803373 - 财政年份:2023
- 资助金额:
$ 13.49万 - 项目类别:
Contributions of IRF5 to Chikungunya Viral Arthritis
IRF5 对基孔肯雅病毒性关节炎的贡献
- 批准号:
10541650 - 财政年份:2021
- 资助金额:
$ 13.49万 - 项目类别:
Mechanisms of STING-associated immunodeficiency
STING 相关免疫缺陷的机制
- 批准号:
10117178 - 财政年份:2019
- 资助金额:
$ 13.49万 - 项目类别:
Mechanisms of STING-associated immunodeficiency
STING 相关免疫缺陷的机制
- 批准号:
10571901 - 财政年份:2019
- 资助金额:
$ 13.49万 - 项目类别:
Mechanisms of STING-associated immunodeficiency
STING 相关免疫缺陷的机制
- 批准号:
10339404 - 财政年份:2019
- 资助金额:
$ 13.49万 - 项目类别:
Contributions of IRF5 to Chikungunya Viral Arthritis
IRF5 对基孔肯雅病毒性关节炎的贡献
- 批准号:
10075631 - 财政年份:2017
- 资助金额:
$ 13.49万 - 项目类别:
相似海外基金
Improving Acute Disease Management for Patients with Alzheimer's Disease and Related Dementias
改善阿尔茨海默病和相关痴呆症患者的急性疾病管理
- 批准号:
10712647 - 财政年份:2001
- 资助金额:
$ 13.49万 - 项目类别:
INDUCTION OF ACUTE DISEASE IN MACAQUES BY NEF GENE VARIANT OF SIVMAC239
SIVMAC239 的 NEF 基因变体在猕猴中诱导急性疾病
- 批准号:
6247642 - 财政年份:1997
- 资助金额:
$ 13.49万 - 项目类别:
INDUCTION OF ACUTE DISEASE IN MACAQUES BY NEF GENE VARIANT OF SIVMAC239
SIVMAC239 的 NEF 基因变体在猕猴中诱导急性疾病
- 批准号:
3718999 - 财政年份:
- 资助金额:
$ 13.49万 - 项目类别:
Neurophysiological alterations in multiple sclerosis patients during acute disease acivity
多发性硬化症患者急性疾病活动期间的神经生理学变化
- 批准号:
465668867 - 财政年份:
- 资助金额:
$ 13.49万 - 项目类别:
Research Grants
SIVMAC 1NEF ALLELE: LYMPHOCYTE ACTIVATION & ACUTE DISEASE IN MACAQUE MONKEYS
SIVMAC 1NEF 等位基因:淋巴细胞激活
- 批准号:
3719026 - 财政年份:
- 资助金额:
$ 13.49万 - 项目类别: